ORTEXORTEX News
Live short interest, options flow, and signals — free on ORTEX.Sign up free →
Market Commentary

Executives Cash Out While Elevance Buys the Dip

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 1 min read

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

Insider filings from the past two weeks reveal a sharp split between sellers and buyers across US equities.

RH CEO dumps $21M. Gary Friedman, Chairman and CEO, filed sales of 125,000 shares worth over $21 million, reported July 8. The trades happened between July 6–8 at prices around $155–$170 per share. A second director also filed a separate sale the same week.

PBF Energy sells top $49.5M block. Billionaire Carlos Slim Helu, a 10% shareholder, filed $49.5M in sales covering 950,000 shares across four days. The filings hit on July 8 and 10. Slim Helu sold between $49 and $53 per share.

Broadcom CLO exits $19.5M. Chief Legal Officer Mark Brazeal sold 50,000 shares for nearly $19.5M, filed July 10. The trades were split evenly across two days at prices near $380–$401.

ServiceTitan VC dumps $49M. Bessemer Venture Partners, a board-level 10% owner, sold over 622,000 shares for $49.2M between July 8–17. The filings came in batches, each just under $8M.

Elevance Health CEO buys. Going against the tide, CEO Gail Boudreaux filed a $1M purchase on July 17. The company's board chairman also bought $366K the same day. Two insiders buying on the same date signals a coordinated show of confidence after Elevance shares have pulled back sharply this year.

Morgan Stanley CFO Sharon Yeshaya also filed $3.5M in sales on July 17, alongside a Head of Division sale worth $5.2M.

This is not financial advice. Data sourced from ORTEX insider filings.

Stocks in this article

How this article was generated

Generated
22 Jul 2026, 16:14
Prompt version
v1.0
Data sources
Institutional positioning

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.